Verus Capital Partners LLC Makes New $260,000 Investment in Axon Enterprise, Inc. (NASDAQ:AXON)

Verus Capital Partners LLC purchased a new position in Axon Enterprise, Inc. (NASDAQ:AXON) during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 650 shares of the biotechnology company’s stock, valued at approximately $260,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the business. Quent Capital LLC raised its holdings in Axon Enterprise by 1,875.0% during the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock worth $32,000 after buying an additional 75 shares during the period. Blue Trust Inc. raised its holdings in Axon Enterprise by 987.5% during the 2nd quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock worth $27,000 after buying an additional 79 shares during the period. Friedenthal Financial acquired a new stake in Axon Enterprise during the 3rd quarter worth about $51,000. Reston Wealth Management LLC acquired a new stake in Axon Enterprise during the 3rd quarter worth about $60,000. Finally, Asset Dedication LLC acquired a new stake in Axon Enterprise during the 2nd quarter worth about $47,000. 79.08% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research firms have issued reports on AXON. Barclays boosted their price objective on Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a report on Wednesday, August 7th. The Goldman Sachs Group boosted their price objective on Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. Jefferies Financial Group began coverage on Axon Enterprise in a research note on Wednesday, July 17th. They set a “buy” rating and a $385.00 target price on the stock. Robert W. Baird lifted their target price on Axon Enterprise from $440.00 to $460.00 and gave the company an “outperform” rating in a research note on Monday, November 4th. Finally, Northland Securities lifted their target price on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday. Two investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $427.83.

Axon Enterprise Trading Up 1.0 %

Shares of NASDAQ AXON opened at $601.29 on Thursday. The stock has a market cap of $45.85 billion, a price-to-earnings ratio of 155.37, a PEG ratio of 14.95 and a beta of 0.94. The business has a 50 day simple moving average of $428.90 and a 200 day simple moving average of $353.54. Axon Enterprise, Inc. has a 52 week low of $220.51 and a 52 week high of $624.84. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96.

Insider Activity at Axon Enterprise

In related news, CFO Brittany Bagley sold 4,338 shares of the business’s stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $378.95, for a total value of $1,643,885.10. Following the completion of the sale, the chief financial officer now owns 98,825 shares of the company’s stock, valued at approximately $37,449,733.75. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In other Axon Enterprise news, CFO Brittany Bagley sold 4,338 shares of the company’s stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $378.95, for a total transaction of $1,643,885.10. Following the completion of the sale, the chief financial officer now owns 98,825 shares of the company’s stock, valued at $37,449,733.75. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $373.03, for a total value of $167,863.50. Following the sale, the director now directly owns 7,379 shares of the company’s stock, valued at $2,752,588.37. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 389,172 shares of company stock valued at $148,393,842. 6.10% of the stock is owned by corporate insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.